Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand.
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
[Neuromyelitis optica spectrum disorder: a case report].
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Ibuprofen-induced unilateral optic neuritis.
Multiple Sclerosis and Venous Abnormalities: Medicine in the Age of Social Media.
The influence of tetracyclines on T cell activation.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Hormone and immune system interactions in demyelinating disease.
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
[Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate].
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

Pages